Vaccine Information
COVID-19 vaccine is available through Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA). Find answers to your questions about getting vaccinated for COVID-19.
- Covid-19 Boosters — Where from Here?
INFORMATION, POSTPONEMENTS, & CANCELLATIONS
• Helpful Guidelines for Remote Work – Managers & Employees.
• Any research protocol involving direct clinical benefits (infusions, injections, oral medications) to study participants will continue to be implemented in the GCRU.
• Biostatistics Drop-In Sessions have been canceled until further notice. Please contact Howard Cabral and Janice Weinberg for any statistical questions.
Community Discussion about COVID-19
The importance of engaging our local community in a discussion about COVID-19 became a priority during the pandemic. The existing partnership with three other MA CTSA’s (Tufts, Harvard, UMass) CE Programs, was leveraged to collaboratively organize a recurring COVID-19 Community Forum series.
COVID-19 BIOREPOSITORY
The COVID-19 Biorepository is an institutional resource available to Boston Medical Center (BMC) and Boston University (BU) researchers interested in biologic samples collected from BMC patients. The goal of the Biorepository is to support innovative and impactful science on the SARS-CoV-2 virus. The Biorepository contains 1) discarded clinical samples from BMC patients (both patients with and without COVID-19), and 2) samples collected from a prospective cohort study of hospitalized BMC COVID-19 patients, with sample collection from ambulatory COVID-19 patient and COVID-19 survivor arms set to begin imminently.
Access to COVID-19 Samples via the MassCPR Sample Sharing System
As many of you know, Boston Medical Center and Boston University are members of the Massachusetts Consortium on Pathogen Readiness (MassCPR). This initiative, led by Harvard Medical School, was convened one year ago with the mission to develop and invest in research projects and infrastructure to address the current global COVID-19 pandemic.
CTSI RESPONSE TO COVID-19 PANDEMIC
Our goal was to accelerate the process of translating COVID-19 lab findings into medical practice and treatments to improve the health and well-being of a diverse patient population.
COVID-19 PUBLICATIONS
- Read the BU/BMC COVID-19 Publications
- Live COVID publication dashboard
- See listed clinical studies from ClinicalTrials.gov
- Find articles from PubMed.gov
FUNDING OPPORTUNITIES
• Information for NIH Applicants and Recipients of NIH Funding
• Funding Opportunities & Open Notices
• Funding Opportunities Specific to COVID-19
COVID-19 Funding Opportunities
NIH COVID-19 Community Engagement Alliance (CEAL) AGAINST COVID-19 Disparities
CEAL focuses on addressing misinformation around COVID-19, engaging trusted partners and messengers in the delivery of accurate information, and educating communities on the importance of inclusion in clinical research to overcome COVID-19, and most importantly, health disparities.
Combat COVID
Clinical trials need people from all age groups, races, ethnicities, and backgrounds. On this website, you can find information about clinical trials you can participate in as well as ways to donate blood and plasma that will lead to prevention and treatment breakthroughs to benefit everyone.
OpenData | COVID-19NCATS is generating a collection of datasets by screening a panel of SARS-CoV-2-related assays against all approved drugs. These datasets, as well as the assay protocols used to generate them, are being made immediately available to the scientific community on this site as these screens are completed.
National COVID Cohort Collaborative (N3C)
The N3C is a partnership among the NCATS-supported Clinical and Translational Science Awards (CTSA) Program hubs and the National Center for Data to Health (CD2H)(link is external), with overall stewardship by NCATS. Collaborators will contribute and use COVID-19 clinical data to answer critical research questions to address the pandemic.
N3C Data Enclave
The N3C Data Enclave is a secure platform through which the harmonized clinical data provided by our contributing members is stored. The data itself can only be accessed through a secure cloud portal hosted by NCATS and cannot be downloaded or removed. N3C invites you to begin your journey with the Enclave and join the collaborative efforts of our partners to better understand and address the most pressing COVID-19 clinical questions.
About ACTIV
LitCovid
LitCovid is a curated literature hub for tracking up-to-date scientific information about the 2019 novel Coronavirus. It is the most comprehensive resource on the subject, providing central access to 80588 (and growing) relevant articles in PubMed. The articles are updated daily and are further categorized by different research topics and geographic locations for improved access.
Global. health
Global. health is a massive epidemiological data collection that enables access to 10 million anonymized Covid-19 records from 160 countries. Each record contains up to 40 data points about the case, including demographics, travel history, testing dates, and outcomes. The project was inspired by just a spreadsheet in the pandemic’s earliest days, an effort born when a group of international epidemiologists decided to collect and openly share granular data on individual Covid-19 cases around the world.
NEJM Covid-19 Articles and Resources
A collection of articles and other resources on the Coronavirus (Covid-19) outbreak, including clinical reports, management guidelines, and commentary.
